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Abstract
Background: Coronary artery disease (CAD) is the leading cause of death in diabetic patients.
Although exercise echocardiography (EE) is established as a useful method for diagnosis and
stratification of risk for CAD in the general population, there are few studies on its value as a
prognostic tool in diabetic patients. The purpose of this investigation was to evaluate the value of
EE in predicting cardiac events in diabetics.
Methods: 193 diabetic patients, 97 males, 59.8 ± 9.3 yrs (mean ± SD) were submitted to EE
between 2001 and 2006 and followed from 7 to 65 months with median of 29 months by phone
calls and personal interviews with patients and their primary physician, and reviewing medical
records and death certificates. The end points were cardiac events, defined as non-fatal myocardial
infarction, late myocardial revascularization and cardiac death. Sudden death without another
explanation was considered cardiac death. Survival free of end points was estimated by the Kaplan-
Meier method.
Results: Twenty-six cardiac events were registered in 24 individuals during the follow-up. The
rates of cardiac events were 20.6 and 7% in patients with positive and negative EE, respectively (p
< 0.001). Predictors of cardiac events included sedentary lifestyle, with RR of 2.57 95%CI [1.09 to
6.02] (P = 0.03) and positive EE, with RR 3.63, 95%CI [1.44 to 9.16] (P = 0.01). Patients with positive
EE presented higher rates of cardiac events at 12 months (6.8% vs. 2.2%), p = 0.004.
Conclusion: EE is a useful method to predict cardiac events in diabetic patients with suspected or
known CAD.
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Background
Diabetes mellitus (DM) is a major risk factor for cardiovas-
cular morbidity and mortality [1-5]. Accordingly, both the
American Heart Association and American College of Car-
diology define DM as an equivalent to previous coronary
artery disease (CAD) for cardiovascular risk [5]. When
associated with other cardiovascular risk factors, DM
increases the rate of macrovascular complications.
The mean annual mortality rate of asymptomatic patients
with multiple cardiovascular risk factors is 3% [6]. In dia-
betic patients, chronic CAD frequently presents reduced
subjective symptoms, unless ventricular dysfunction is
present [7]. Recognition of subclinical ischemic disease in
diabetic patients and stratification of risk are important to
select therapeutic interventions and to reduce the compli-
cations of cardiac events [2,7-10].
Exercise echocardiography (EE) is a valuable method for
diagnosis, risk stratification and prognosis of CAD [3,11-
14]. This technique has the advantages of wide availabil-
ity, safety and low cost, provides information on left ven-
tricular function, exercise capacity, and presence, location
and extension of wall motion abnormalities [15]. The sen-
sitivity of EE to detect coronary arteries obstructions varies
between 70 and 100% [15,16]. EE is similar to myocardial
perfusion scintigraphy in diagnosing CAD and even supe-
rior in determining its extension [15]. This is particularly
relevant, as the extension of ischemia and the severity of
wall motion abnormalities are considered independent
and cumulative predictors of prognosis in patients with
CAD [3,9].
The aim of the present study was to evaluate the prognos-
tic value of EE in diabetic patients.
Patients and methods
Subjects
We retrospectively reviewed the records of 193 diabetic
patients with suspected or known CAD who were referred
by their physicians for diagnosis or risk stratification in
the Laboratory of Echocardiography of São Lucas Hospital
(city of Aracaju, State of Sergipe, Brazil) to undergo EE
from March 2001 to January 2006.
All patients but one had type 2 diabetes based on referring
physicians' assessment. This group was formed by mostly
middle-class patients, with access to private health insur-
ance services. Diabetic patients with significant co-mor-
bidities, such as cancer, end-stage renal disease, severe
obstructive and pulmonary disease, were not included in
this analysis.
DM was defined as the presence of fasting plasma glucose
≥ 126 mg/dl on at least two occasions, or by the use of
insulin or oral hypoglycemic agents [17]. Hypercholester-
olemia was defined as serum total cholesterol levels ≥ 200
mg/dl (after a 12-hour fasting) or by the use of hypolipi-
demic agents (statins and/or fibrates). Metabolic control
was assessed by the level of fasting plasma glucose, total
cholesterol, LDL-cholesterol, HDL-cholesterol, and trig-
lycerides nearest to the interview [18]. Systemic hyperten-
sion was defined as resting blood pressure measurements
on upper limb ≥ 140/90 mmHg or by the use of antihy-
pertensive medication [19].
The International Physical Activity Questionnaire (IPAQ)
was used to define sedentary lifestyle. Participants were
classified as active if they accumulated more than 150
minutes per week of moderate to vigorous physical activ-
ity or more than 60 minutes per week of vigorous physical
activity. If not, they were considered sedentary [20]. The
study was approved by the Ethics and Research Commit-
tee of Federal University of Sergipe and all subjects gave
written informed consent.
Follow-up
Information from patient follow-up was obtained by tele-
phone interviews, household visits, or contact with the
primary physician and review of medical records and/or
death certificates. Cardiac events occurred after exercise
echocardiography included late myocardial revasculariza-
tion (LMR), nonfatal myocardial infarction (MI) –
defined according to current guidelines [21] – and cardiac
death, including sudden unexpected deaths without
another explanation. Registered hard events were nonfatal
MI and cardiac death. Deaths of presumable non-cardiac
causes were all registered. The median follow-up was 29
months, range 7 to 65 months. Percentiles 25 and 75 were
16 and 43 months, respectively. Patients were divided
into two groups: G1, 92 (47%) patients with EE that was
positive for myocardial ischemia; G2, 101 (53%) patients
with EE negative for myocardial ischemia.
Study Protocol
Exercise Echocardiography
All patients underwent symptom-limited treadmill exer-
cise testing according to the standard Bruce protocol.
Heart rate (HR) was continuously recorded, and patients
were strongly encouraged to reach > 85% of maximal age-
predicted HR. The exercise was interrupted whenever the
maximal age-predicted HR was exceeded or in the pres-
ence of the following signs and/or symptoms: chest pain,
shortness of breath, muscle fatigue, hypertension (blood
pressure ≥ 220/120 mmHg), hypotension (reduction of
blood pressure at rest during exercise), syncope and severe
arrhythmias. During the test, the individuals were contin-
uously monitored with a three-lead electrocardiogram.
Exercise test was considered positive for myocardial
ischemia if there was a horizontal or down-sloping ST-seg-Cardiovascular Ultrasound 2009, 7:24 http://www.cardiovascularultrasound.com/content/7/1/24
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ment depression, of ≥ 1 mm for men and 1.5 mm for
women, at 80 ms after the J point. In the presence of elec-
trocardiographic changes which were suggestive of the left
bundle branch block, left ventricular hypertrophy, pre-
excitation syndrome and use of digitalis, the ECG was
considered non-diagnostic [22]. Echocardiograms were
performed with Hewlett-Packard/Phillips SONOS 5500
systems, Palo Alto, Calfornia, USA. Two-dimensional
echocardiographic images were obtained from the par-
asternal and apical windows at rest and immediately after
exercise. Both, digitized and videotape-recorded or digital
video display (DVD), were used for the interpretation of
the studies [23]. Regional wall motion was assessed semi
quantitatively by experienced echocardiographer, with
level III training, as recommended by the American Soci-
ety of Echocardiography. Wall motion at rest and with
exercise was scored from 1 through 4 (1, normal; 2, hypo-
kinesis; 3, akinesis; 4, dyskinesis) according to a 16-seg-
ment model [24]. Wall motion score index (WMSI), was
determined at rest and peak exercise as the sum of the seg-
mental scores divided by the number of visualized seg-
ments. In order to evaluate ischemia, wall motion
abnormalities in positive EE were defined as: (a) myocar-
dial ischemia: development of a wall motion abnormality
with exercise; (b) fixed ischemia: wall motion abnormal-
ity present at rest and unchanged with exercise; (c) fixed
and induced ischemia: wall motion abnormality at rest
that worsens or appears in a different segment with exer-
cise [25,26].
Statistical analysis
Continuous variables were reported as mean ± SD or
median and interquatile range. Comparisons between
groups were performed with student's t test. Categorical
variables were summarized as percentages, and group
comparisons were based on chi-square test. Survival free
of events was estimated by the Kaplan-Meier method.
Univariable and multivariable association of clinical, elec-
trocardiographic and echocardiographic variables with
cardiac events were assessed in the Cox proportional haz-
ards framework and the results were summarized as risk
ratios with corresponding 95% confidence intervals (CIs).
Probability values less than or equal to 0.05 were consid-
ered statistically significant. Statistical analyses were per-
formed using the SPSS 13.0 (SPSS, Chicago, IL).
Results
Subject characteristics
A total of 193 patients (97 men) with mean age of 59.8 ±
9.3 years (range 38 to 91 years) were studied. Fifty-two
patients (26.9%) used insulin (with or without oral
hypoglycemic agents), 46 patients (24%) had previous
myocardial revascularization and 28 (14.5%) had previ-
ous MI. The most frequent cardiovascular risk factors in
the group studied were systemic hypertension, hypercho-
lesterolemia and sedentary lifestyle.
Clinical features of patients in groups G1 and G2 were
similar, except use of insulin (34.8% vs.19.8%, P = 0.02),
beta blockers (30.4% vs. 8.9%, P < 0.001) and nitrate
(15.2% vs. 5.9%, P = 0.03), which were all higher in
Table 1: Clinical features of patients with abnormal (G1) and normal (G2) exercise echocardiography
VARIABLES G1 (n = 92) G2 (n = 101) P
Males (%) 44 (47.8%) 53 (52.5%) 0.52
Age (Years) 60.4 ± 9.5 59.3 ± 9.1 0.42
Systemic Hypertension (%) 81 (88%) 90 (89.1%) 0.82
Fasting Plasma Glucose 143.0 ± 44.1 149.2 ± 42.6 0.83
Total Cholesterol 187.0 ± 47.8 191.6 ± 45.5 0.95
HDL-Cholesterol 50.7 ± 16.8 48.3 ± 13.0 0.55
LDL-Cholesterol 109.5 ± 46.8 110.1 ± 40.3 0.7
Triglycerides 163.2 ± 142.8 173.9 ± 83.2 0.43
Cigarette Smoking (%) 22 (23.9%) 19 (18.8%) 0.39
Sedentary (%) 45 (48.9%) 45 (44.6%) 0.54
BMI 27.9 ± 4.2 28.9 ± 3.8 0.11
Family History of IHD (%) 38 (41.3%) 34 (33.7%) 0.27
Alcoholism (%) 40 (43.5%) 45 (44.6%) 0.88
Insulin Therapy (%) 32 (34.8%) 20 (19.8%) 0.02
Oral Hypoglycemic Agents (%) 68 (73.9%) 83 (82.2%) 0.16
Beta Blocker Therapy (%) 43 (47.8%) 29 (29.3%) 0.009
Nitrates Therapy (%) 33 (36.7%) 6 (6.1%) <0.001
Ca++Channel Blocker Therapy (%) 33 (36.7%) 30 (30.3%) 0.35
BMI = Body Mass Index
IHD = Ischemic heart diseaseCardiovascular Ultrasound 2009, 7:24 http://www.cardiovascularultrasound.com/content/7/1/24
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patients with positive EE. There were not differences in
metabolic control in the two groups (Table 1).
Follow-up
Twenty-four patients (12.4%) presented cardiac events
during the follow-up. Group G1 had 19 cardiac events: 4
MI, 11 LMR and 4 cardiac deaths. Seven cardiac events
occurred in Group G2: 2 MI, 3 LMR and 2 cardiac deaths.
One patient in each group had two events during the fol-
low-up (MI and LMR) and the overall rate of these major
cardiac events in both groups was 13.5% LMR was more
frequent in group G1 (12% vs. 3%; p < 0.001) (Table 2).
The analysis of cardiac events in diabetics with normal EE
demonstrated that MI's occurred 10 and 25 months after
the echocardiography, while LMR's occurred after periods
of 25, 21 and 12 months. The cardiac deaths happened 27
and 53 months after the EE.
Exercise echocardiography
Diabetic patients that achieved above the maximal age-
predicted heart rate during EE presented positive EE less
frequently that the ones that did not achieved it (7.5% vs.
32.7%, P = 0.004).
There was no difference in resting and peak exercise heart
rates and blood pressure between G1 and G2. Resting
ejection fraction was higher in group G2 (0.64 ± 0.07 vs.
0.66 ± 0.05, P = 0.01). Patients from group G1 presented
higher WMSI at rest and peak exercise (P < 0.001) (Table
3).
Independent predictors of cardiac events included seden-
tary lifestyle, with RR of 2.57 95%CI [1.09 to 6.02] (P =
0.03) and positive EE, with RR 3.63, 95%CI [1.44 to 9.16]
(P = 0.01).
In the analysis of survival free of end points, the events
rate was higher in patients with ischemic EE, in compari-
son to those with normal result at 12 (6.8% vs. 2.2%), 24
(15% vs. 3.4%) and 65 months (29% vs. 15.8%), P =
0.004 (Fig. 1).
Sedentary diabetic patients had higher rates of cardiac
events in comparison to active diabetics at 12 (4.6% vs.
4.2%), 24 (11.3% vs. 6.7%) and 57 months (34.1% vs.
12%), P = 0.03 (Fig. 2)(Additional Files 1, 2, 3, 4 and 5).
Discussion
Identification of patients with subclinical disease and
high risk of future cardiac events occurrence is a strategy
that aims to reduce the risk of complications of CAD [2,8].
The value of EE in prognostic stratification of diabetic
patients with known or suspected CAD has been previ-
ously reported [3,27].
In the present study, the number of positive EE was higher
than reported in the general population [14], confirming
the higher risk of CAD in diabetic patients. A higher
number of patients with normal EE reached above maxi-
mal age-predicted heart rate (P = 0.004). Patients with
ischemic EE presented higher levels of WMSI at rest and
during peak of exercise (P < 0.0001). Resting ejection frac-
tion was lower in diabetics with positive EE (0.64 ± 0.07
vs. 0.66 ± 0.05, P = 0.01), although both fell within nor-
mal values, suggesting that the G1 group did not have
heart failure.
Table 2: Hemodynamic and echocardiographic features of patients with abnormal (G1) and normal (G2) exercise echocardiography
VARIABLES G1 (n = 92) G2 (n = 101) P
Failure to Achieve 85% of the Maximal Age-predicted Heart Rate 30 (32.6%) 31 (30.7%) 0.77
Achieved 85% of the Maximal Age-predicted Heart Rate 32 (34.8%) 24 (23.8%) 0.09
Achieved Maximal Age-predicted Heart Rate 12 (13%) 23 (22.8%) 0.08
Achieved Above Maximal Age-predicted Heart Rate 3 (7.5%) 16 (32.7%) 0.004
Resting Heart Rate 113.5 ± 35.9 116.2 ± 39.3 0.62
Peak Exercise Heart Rate 164 ± 29.2 170.5 ± 25.6 0.11
Resting Systolic Blood Pressure 159.6 ± 30.4 163.8 ± 36.3 0.38
Resting Diastolic Blood Pressure 86.7 ± 18.6 83.1 ± 14.7 0.14
Peak Exercise Systolic Blood Pressure 162.2 ± 32.9 163 ± 31.2 0.86
Peak Exercise Diastolic Blood Pressure 88.4 ± 11.6 87.5 ± 9.8 0.56
Final Systolic Blood Pressure 107.6 ± 35.2 108.8 ± 36 0.81
Final Diastolic Blood Pressure 35.8 ± 40.3 38.1 ± 38.6 0.68
Resting Ejection Fraction 0.64 ± 0.07 0.66 ± 0.05 0.008
WMSI* at Rest 1.06 (0.12)† 1.00 (0.00)† < 0.001
WMSI* Peak Exercise 1.12 (0.18)† 1.00 (0.00)† < 0.001
Values are means ± SD
WMSI = Wall Motion Score Index
† Median (interquatile range) Mann-Whitney testCardiovascular Ultrasound 2009, 7:24 http://www.cardiovascularultrasound.com/content/7/1/24
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The rate of cardiac events was higher in patients with
ischemic EE in comparison to those with a normal result,
despite comparable metabolic control. In a similar study,
Elhendy et al. [3] followed up 563 diabetic patients with
known or suspected ischemic heart disease who under-
went EE for a median period of three years. Fifty patients
(9%) experienced cardiac events during the follow-up.
Similar to our study, the rate of events was higher in
patients with positive EE, in comparison to patients with
normal results (11.9% vs. 1.8% in three years). The fre-
quency of hard events was higher than ours, possibly
related to the socio-economic profile of our patients, with
access to private health insurance services and high qual-
ity of medical care. Alternatively, the high number of LMR
may have reduced the number of hard events in our
group. In their study, none of the patients with normal EE
presented cardiac events in the first two years of follow up.
However, the rate of events increased gradually after two
years, achieving 7.6% by the end of the fifth year. Our
patients behaved similarly, since in patients with normal
EE only one event occurred during the first year of follow-
up, and the rate of events increased gradually after the sec-
ond year and reached 15.8% by the end of the fifth year.
The authors related this finding to progression of ischemic
disease and recommended repeating EE after two years, as
a strategy for reassessing the risk status of patients with an
initial normal result. Our data suggest that it is better to
repeat the EE each year, because one MI occurred 10
months and one LMR 12 months after a normal EE. We
also found by multivariate analysis that sedentary lifestyle
and positive EE were predictors for cardiac events, while to
Elhendy et al., MI, ejection fraction at rest, and percentage
of ischemic segments during exercise were the most
important predictors [3].
Garrido et al. [11] assessed the value of EE for prediction
of cardiac events in 214 patients with DM. Twenty-eight
developed cardiac events (15 cardiac deaths and 13 MI)
during a follow-up of 44 ± 16 months. This study
described the following independent risk factors as pre-
dictor of future cardiac events: use of insulin, ventricular
ejection fraction in peak exercise and, similar to our study,
myocardial ischemia detected by EE. More recently, Cor-
Table 3: Cardiac events in patients with abnormal (G1) and 
normal (G2) exercise echocardiography
VARIABLES G1 (n = 92) G2 (n = 101) P
Myocardial infarction 4 (4.3%) 2 (2%) 0.113
Late myocardial reperfusion 11 (12%) 3 (3%) <0.001
Death 4 (4.3%) 2 (2%) 0.113
Total 19 (20.6%) 7 (7%) <0.001
Kaplan-Meier curves for survival free of cardiac events in patients with normal (gray line) vs. abnormal (black line) exercise  echocardiography (EE) Figure 1
Kaplan-Meier curves for survival free of cardiac events in patients with normal (gray line) vs. abnormal (black 
line) exercise echocardiography (EE).Cardiovascular Ultrasound 2009, 7:24 http://www.cardiovascularultrasound.com/content/7/1/24
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tigiani et al. [28] studied the prognostic value of pharma-
cological stress echocardiography in 149 diabetic and 786
non-diabetic patients with chest pain and intermediate to
high threshold positive exercise results, with a median fol-
low-up of 26 months. They recorded 51 deaths, 29 MI and
79 LMR, with a rate of major events of 26% in diabetics,
higher than our global rate of 13.5%, probably due to
more severe cardiovascular disease in the entry of that
study. They concluded that a non-ischemic test predicts a
6-month period free of major events, and a 2% major
event rate at 1-year-follow-up in both populations, with
marked increase of major events rate in diabetic patients
afterwards. These data are in agreement with our finding
of a gradual increase in risk after the second year and a
15.8% rate by the end of the fifth year.
Sozzi et al demonstrated that an abnormal dobutamine
stress echocardiography was associated with a higher mor-
tality compared with a normal dobutamine stress echocar-
diogram (p = 0.03) in asymptomatic diabetic patients
with no previous CAD [27].
The last consensus of stress echocardiography experts [29]
stated that inducible myocardial ischemia in echocardiog-
raphy by physical or pharmacological stress present a
comparable prognostic value. It has also been suggested
that patients with ischemic left ventricular dysfunction
and a significant amount of viable myocardium have bet-
ter prognosis, with lower perioperative mortality, greater
improvements in global and regional left ventricular func-
tion and higher long-term survival after revascularization
than patients with non-viable myocardium. In addition to
that, coronary flow reserve and wall motion analysis offer
complementary data during stress echocardiography. The
combination of these two parameters improves the prog-
nostic value. A reduced coronary flow reserve is a parame-
ter of ischemic severity in risk stratification of EE response
whereas patients with a negative test for wall motion cri-
teria and normal coronary flow reserve have a favorable
outcome during dypiridamole stress echocardiography.
At this moment, our echocardiography laboratory has a
larger data base than the one used in this manuscript, and
a research is currently being developed concerning prog-
nostic value of EE in all the patients, diabetic and non-dia-
betic. Therefore, in this study, we cannot assess the impact
of revascularization procedures in both groups. Previous
reports demonstrated that diabetic patients with a normal
EE result present worse outcomes in comparison to their
age-matched non-diabetic counterparts [30]. In addition
to that, Cortigiani et al found abnormal coronary flow
reserve in the left anterior descending to be a strong, inde-
pendent and additive prognostic indicator in a large
cohort of diabetic and non-diabetic patients with known
Kaplan-Meier curves for survival free of cardiac events in diabetic patients according to lifestyle Figure 2
Kaplan-Meier curves for survival free of cardiac events in diabetic patients according to lifestyle. Black line: active 
patients; Gray line: sedentary patients.Cardiovascular Ultrasound 2009, 7:24 http://www.cardiovascularultrasound.com/content/7/1/24
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or suspected CAD and negative dypiridamole stress
echocardiography. Thus, a negative test was less prognos-
tically benign in diabetic patients than in age-matched
non-diabetic patients [31].
Our study has some important limitations. One is the lack
of data on the duration of DM. Second, the group of dia-
betics studied was formed by middle-class patients, with
access to private health insurance services. Therefore, the
results of this study may not be valid to populations of dif-
ferent socio-economic backgrounds. Third, post-test bias
could not be eliminated, since the EE results were availa-
ble to the treating physicians. Therefore, a test result posi-
tive for myocardial ischemia may have influenced the
decision of performing myocardial revascularization, so
that patients with a higher risk may have undergone revas-
cularization, possibly reducing the rate of hard events. In
addition, positive results in EE may have influenced in the
choice of medication for these patients, also reducing the
possibility of occurrence of cardiac events. These interven-
tions, however, would reduce rather than increase the risk
of ischemic events. Finally, we cannot rule out that a sub-
set of subjects that we could not locate may have died.
However, the prevalence of normal and abnormal EE in
this group was almost identical, making it unlikely that
this factor may have altered significant our findings.
Conclusion
EE is a useful method to define survival free of cardiac
events in diabetic patients with known or suspected
ischemic heart disease, providing additional prognostic
information to clinical and exercise electrocardiographic
variables at rest. This technique may be useful for prog-
nostic evaluation and risk stratification of patients who
have DM.
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RS, female patient, 73 years-old, active, BMI = 21 kg/m2, complain-
ing of typical chest pain, hypertensive, with family history of coronary 
artery disease and previous exercise  testing negative for myocardial 
ischemia. In exercise echocardiography, left ventricular mass index = 
106.1 g/m2. Ejection fraction = 0.69, peak exercise heart rate = 145 
beats/min, WMSI in peak exercise = 1.13. Time spent in treadmill exer-
cise = 6.57 minutes, 2.5 mph, achieved second stage in Bruce protocol. In 
peak exercise, presented hypokinesis in anterior and lateral-apical walls.




ILA,female patient, 61 years-old, active, BMI = 29.9 kg/m2, complain-
ing of atypical chest pain, hypertensive, dyslipidemic, with family his-
tory of coronary artery disease and previous exercise testing negative 
for myocardial ischemia. In exercise echocardiography, left ventricular 
mass index = 88.5 g/m2, ejection fraction = 0.69, peak exercise heart rate 
= 150 beats/min, WMSI in peak exercise = 1.13. time spent in treadmill 
exercise = 9 minutes, 3.4 mph, achieved the third stage of Bruce protocol. 
In peak exercise, presented hypokinesis in anterior and lateral-apical 
walls.




MDA, female patient, 47 years-old, sedentary lifestyle, BMI = 32 kg/
m2, complaining of atypical chest pain, hypertensive, previous exercise 
testing positive for myocardial ischemia. In exercise echocardiography, 
presented left ventricular mass index = 79.8 g/m2, ejection fraction = 
0.67, peak exercise heart rate = 174 beats/min, WMSI in peak exercise = 
1. Time spent in treadmill exercise = 8.32 minutes, 2.5 mph, achieved the 
second stage in Bruce protocol. Wall motion in peak exercise was normal.




JCA male patient, 43 years-old, active, BMI = 22.46 kg/m2. History of 
myocardial infarction three years ago, complaining of atypical chest pain, 
hypertensive, dyslipidemic, with family history of coronary artery disease 
and precious exercise testing negative for myocardial ischemia. In exercise 
echocardiography, presented left ventricular mass index = 114.8 g/m2, 
ejection fraction = 0.56, peak exercise heart rate = 183 beats/min, WMSI 
in peak exercise = 1.13. Time spent in treadmill exercise = 12.53 minutes, 
5.0 mph, achieved the fifth stage in Bruce protocol. Both at rest and in 
peak exercise presented hypokinesis in inferior-basal and inferior-medial 
walls.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-7-24-S4.wmv]Cardiovascular Ultrasound 2009, 7:24 http://www.cardiovascularultrasound.com/content/7/1/24
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